Lung Immune Challenge Study: Controlled Exposure to Inhaled Resiquimod (R848)
Not Applicable
Recruiting
- Conditions
- Mucosal ImmunityAsthmaViral InfectionInnate Immunity
- Interventions
- Drug: Saline
- First Posted Date
- 2024-07-05
- Last Posted Date
- 2024-07-10
- Lead Sponsor
- Akhilesh Jha
- Target Recruit Count
- 36
- Registration Number
- NCT06488118
- Locations
- 🇬🇧
NIHR Cambridge Clinical Research Facility, Cambridge, Cambridgeshire, United Kingdom
© Copyright 2025. All Rights Reserved by MedPath